Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Mar ‘25 |
|
|---|---|---|---|---|---|
| $21M | $96.9M | $75.8M | 7.15% |
|
|
| $20.9M | $37.8M | $16.9M | 126% |
|
|
| $20.9M | $35.1M | $14.3M | 30.1% |
|
|
654
CRISPR Therapeutics
CRSP
$5.1B
| $20.7M | $96.3M | $75.6M | 57.1% |
|
| $20.7M | $23.3M | $2.55M | 57.4% |
|
|
| $20.7M | $49.4M | $28.7M | 120% |
|
|
| $20.6M | $62.3M | $41.7M | 57.3% |
|
|
| $20.5M | $60.1M | $39.6M | 20.3% |
|
|
| $20.5M | $29.1M | $8.6M | 11.2% |
|
|
| $20.5M | $34.8M | $14.3M | 30.4% |
|
|
661
Entegris
ENTG
$11.7B
| $20.5M | $45.6M | $25.1M | 11.8% |
|
| $20.5M | $20.9M | $477K | 73.4% |
|
|
| $20.4M | $44.8M | $24.3M | 37.7% |
|
|
| $20.4M | $25.1M | $4.72M | 75.4% |
|
|
| $20.3M | $127M | $106M | 9.56% |
|
|
| $20.3M | $53.4M | $33.1M | 96.9% |
|
|
| $20.2M | $26.6M | $6.4M | 39.1% |
|
|
| $20.2M | $24M | $3.79M | 0.36% |
|
|
| $20M | $25.6M | $5.62M | 46.5% |
|
|
| $20M | $35.7M | $15.7M | 27.6% |
|
|
| $20M | $54M | $34M | 0.46% |
|
|
| $19.8M | $20.5M | $628K | 3.07% |
|
|
| $19.8M | $46.3M | $26.5M | 8.48% |
|
|
| $19.7M | $30.8M | $11.1M | 10.3% |
|
|
| $19.7M | $24.5M | $4.83M | 22.6% |
|